affected gene[s]) are at best poorly understood. Thus, it is usually not clear whether the therapeutic goal would be to enhance or decrease the actions of the implicated gene product. And, critically, since each gene independently contributes such a small amount of the variance, a drug may well not produce significant therapeutic traction even if it were perfect at correcting the abnormality.
